Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

U. Pelzer · SciRah

Researcher profile · Semantic Scholar

U. Pelzer

Share profile

U. Pelzer — researcher profile on SciRah

h-index: 38
Works: 214
Citations: 6,221

Most-cited papers

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
R. K. Kelley, M. Ueno, C. Yoo, R. Finn +17 more
2023The Lancet882 citations Open access
Semantic Scholar
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
V. Kunzmann, J. Siveke, H. Algül, E. Goekkurt +33 more
2020The Lancet Gastroenterology and Hepatology156 citations
Semantic Scholar
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
M. Tempero, U. Pelzer, E. O'Reilly, J. Winter +27 more
2022Journal of Clinical Oncology116 citations Open access
Semantic Scholar
The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta‐analysis
N. Es, M. Ventresca, M. Di Nisio, Qi Zhou +37 more
2020Journal of Thrombosis and Haemostasis100 citations Open access
Semantic Scholar
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression
Phyllis F. Cheung, Jiajin Yang, Rui Fang, Arianna Borgers +31 more
2022Nature Communications72 citations Open access
Semantic Scholar
Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach
F. Krenzien, N. Nevermann, Alina Krombholz, C. Benzing +7 more
2022Cancers66 citations Open access
Semantic Scholar
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer
A. Stein, D. Simnica, C. Schultheiss, R. Scholz +23 more
2021Journal for ImmunoTherapy of Cancer63 citations Open access
Semantic Scholar
Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study
B. Schultheis, D. Strumberg, J. Kuhlmann, M. Wolf +8 more
2020Cancers60 citations Open access
Semantic Scholar
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE).
M. Kundranda, A. C. Gracián, S. Zafar, E. Meiri +13 more
2020Annals of Oncology49 citations Open access
Semantic Scholar
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)
I. Hartlapp, D. Valta-Seufzer, J. Siveke, H. Algül +17 more
2022ESMO Open42 citations Open access
Semantic Scholar
Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC): Final results of the phase II AVETUX trial (AIO-KRK-0216).
A. Stein, M. Binder, E. Goekkurt, S. Lorenzen +12 more
202039 citations
Semantic Scholar
Prognostic and Predictive Molecular Markers in Cholangiocarcinoma
Sandra Pavicevic, Sophie Reichelt, D. Uluk, I. Lurje +13 more
2022Cancers38 citations Open access
Semantic Scholar
Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study
J. Striefler, H. Riess, P. Lohneis, S. Bischoff +10 more
2021Frontiers in Oncology38 citations Open access
Semantic Scholar
TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial
M. Sinn, B. Sinn, D. Treue, U. Keilholz +13 more
2020Clinical Cancer Research38 citations Open access
Semantic Scholar
Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies?
M. Felsenstein, Flora Lindhammer, M. Feist, K. Hillebrandt +11 more
2022Journal of Clinical Medicine34 citations Open access
Semantic Scholar
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis.
H. Schunemann, M. Ventresca, M. Crowther, M. Briel +35 more
2020The Lancet Haematology30 citations Open access
Semantic Scholar
A tailored approach in lymph node-positive perihilar cholangiocarcinoma
C. Benzing, F. Krenzien, A. Mieg, Annika Wolfsberger +9 more
2021Langenbeck's archives of surgery (Print)25 citations Open access
Semantic Scholar
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
K. Hoyer, R. Hablesreiter, Y. Inoue, K. Yoshida +19 more
2021EBioMedicine24 citations Open access
Semantic Scholar
Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it’s not all about size
Johannes Kolck, T. Auer, T. Walter-Rittel, Clarissa Hosse +10 more
2023Abdominal Radiology23 citations Open access
Semantic Scholar
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final results.
M. Sinn, T. Liersch, H. Riess, K. Gellert +16 more
2020European Journal of Cancer23 citations
Semantic Scholar
Translational analysis and final efficacy of the AVETUX trial – Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer
J. Tintelnot, I. Ristow, M. Sauer, D. Simnica +23 more
2022Frontiers in Oncology22 citations Open access
Semantic Scholar
Influence of Baseline CT Body Composition Parameters on Survival in Patients with Pancreatic Adenocarcinoma
N. Beetz, D. Geisel, Christoph Maier, T. Auer +5 more
2022Journal of Clinical Medicine19 citations Open access
Semantic Scholar
Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients—A Single-Center Analysis of 1294 Patients within the Last Decade
Christopher C. M. Neumann, François Schneider, G. Hilfenhaus, L. Vecchione +8 more
2023Cancers17 citations Open access
Semantic Scholar
Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial
M. Ghadimi, U. Pelzer, M. Besselink, J. Siveke +18 more
2025BMC Cancer16 citations Open access
Semantic Scholar
68Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapy
G. Metzger, C. Bayerl, J. Rogasch, C. Furth +12 more
2024Theranostics16 citations Open access
Semantic Scholar
Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001)
M. Schmelzle, C. Benzing, L. Fischer, U. Herden +25 more
2022Frontiers in Oncology14 citations Open access
Semantic Scholar
Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
T. Auer, F. Collettini, L. Segger, U. Pelzer +7 more
2023Cancers13 citations Open access
Semantic Scholar
Impact of a specialised palliative care intervention in patients with advanced soft tissue sarcoma – a single-centre retrospective analysis
F. Brandes, J. Striefler, A. Dörr, M. Schmiester +9 more
2021BMC Palliative Care13 citations Open access
Semantic Scholar
Influence of the body mass index on postoperative outcome and long-term survival after pancreatic resections in patients with underlying malignancy.
P. Seika, F. Klein, U. Pelzer, J. Pratschke +2 more
2019Hepatobiliary surgery and nutrition13 citations Open access
Semantic Scholar
Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma - A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials.
A. Kurreck, Johanna Weckwerth, D. Modest, J. Striefler +7 more
2021European Journal of Cancer11 citations
Semantic Scholar
Quality of life and added value of a tailored palliative care intervention in patients with soft tissue sarcoma undergoing treatment with trabectedin: a multicentre, cluster-randomised trial within the German Interdisciplinary Sarcoma Group (GISG)
L. Hentschel, S. Richter, H. Kopp, B. Kasper +12 more
2020BMJ Open11 citations Open access
Semantic Scholar
Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5th edition of the World Health Organization classification
T. Auer, Sebastian Halskov, U. Fehrenbach, N. Nevermann +7 more
2023European Radiology10 citations Open access
Semantic Scholar
Body composition is associated with disease aetiology and prognosis in patients undergoing resection of intrahepatic cholangiocarcinoma
I. Lurje, D. Uluk, Sandra Pavicevic, M. Phan +12 more
2023Cancer Medicine9 citations Open access
Semantic Scholar
Ultrasound Time-Harmonic Elastography of the Pancreas
Christian Burkhardt, H. Tzschätzsch, R. Schmuck, M. Bahra +6 more
2020Investigative Radiology9 citations
Semantic Scholar
A surgical strategy for intrahepatic cholangiocarcinoma — the hilar first concept
N. Nevermann, J. Bode, M. Vischer, Lina Feldbrügge +9 more
2023Langenbeck's archives of surgery (Print)8 citations Open access
Semantic Scholar
The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation
S. Gül-Klein, P. Schmitz, W. Schöning, Robert Oellinger +9 more
2022Cancers8 citations Open access
Semantic Scholar
Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial.
R. Issels, S. Boeck, U. Pelzer, U. Mansmann +38 more
2022European Journal of Cancer8 citations
Semantic Scholar
Cachexia-Affected Survival Based on Inflammatory Parameters Compared to Complex Conventional Nutritional Assessments in Patients with Pancreatic Cancer and Other Gastrointestinal Tumors—The CONKO 020 Investigation
J. Meyer-Knees, Janina Falkenthal, D. Geisel, Christopher C. M. Neumann +7 more
2024Cancers7 citations Open access
Semantic Scholar
FOOTPATH: A randomized, open-label phase-2 study of liposomal irinotecan + 5-FU and folinic acid (NAPOLI) versus sequential NAPOLI and mFOLFOX6 versus gemcitabine/nab-paclitaxel in treatment-naïve metastatic pancreatic cancer (mPDAC).
B. Westphalen, T. Gaska, M. Reichert, Michael Quante +16 more
2023Journal of Clinical Oncology7 citations
Semantic Scholar
Neoadjuvant Chemotherapy Enhances Local Postoperative Histopathological Tumour Stage in Borderline Resectable Pancreatic Cancer – A Matched-Pair Analysis
L. Timmermann, N. Rosumeck, F. Klein, J. Pratschke +3 more
2019Anticancer Research7 citations Open access
Semantic Scholar
Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoids
Katharina Wansch, U. Pelzer, François Schneider, Florian Dölvers +15 more
2025Cancer Cell International6 citations Open access
Semantic Scholar
Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients—A Single Center Analysis of 2323 Patients within the Last Decade
Christopher C. M. Neumann, François Schneider, Georg Hilfenhaus, L. Vecchione +7 more
2023Journal of Clinical Medicine6 citations Open access
Semantic Scholar
Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma.
Hannah Muenzfeld, S. Mahjoub, R. Roehle, U. Pelzer +5 more
2019European Journal of Radiology6 citations
Semantic Scholar
Reduced monocytic IL10 expression in PD1 inhibitor-treated patients is a harbinger of severe immune-related adverse events.
S. Rosnev, Baldur Sterner, P. Schiele, S. Kolling +17 more
2025European Journal of Cancer5 citations Open access
Semantic Scholar
Technical Recommendation on Multi-Driver Multifrequency MR Elastography for Tomographic Mapping of Abdominal Stiffness With a Focus on the Pancreas and Pancreatic Ductal Adenocarcinoma.
J. Schattenfroh, Salma Almutawakel, J. Bieling, J. Castelein +20 more
2025Investigative Radiology5 citations Open access
Semantic Scholar
DNA methylation classifier to diagnose pancreatic ductal adenocarcinoma metastases from different anatomical sites
Teodor G. Calina, E. Perez, Elena Grafenhorst, J. Benhamida +18 more
2024Clinical Epigenetics5 citations Open access
Semantic Scholar
METAPANC, intensified treatment in patients with oligometastatic pancreatic cancer: Multimodal surgical treatment versus systemic chemotherapy alone—A prospective randomized controlled multicenter phase III trial.
Peter Jo, M. Ghadimi, U. Pelzer, M. Crede +6 more
2024Journal of Clinical Oncology5 citations
Semantic Scholar
Cancer-Associated Venous Thromboembolism—Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline
H. Riess, J. Beyer-Westendorf, U. Pelzer, R. Klamroth +1 more
2023Hämostaseologie5 citations Open access
Semantic Scholar
The basis for future personalized therapy approaches - Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients.
François Schneider, Haotian Chen, U. Pelzer, Richard G. Compton +14 more
2025European Journal of Cancer4 citations Open access
Semantic Scholar
CONKO-011/AIO-SUP-0115/ass.: Rivaroxaban Compared to Low Molecular Weight Heparin in Cancer Patients with Acute Venous Thromboembolism
M. Sinn, Anja Lohneis, O. Mohamed, C. Roderburg +13 more
2025Oncology Research and Treatment4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Bahra×11
Invite
M. Bahra — researcher profile on SciRah
J. Pratschke×11
Invite
J. Pratschke — researcher profile on SciRah
W. Schöning×11
Invite
W. Schöning — researcher profile on SciRah
U. Fehrenbach×10
Invite
U. Fehrenbach — researcher profile on SciRah

×9

Invite

D. Geisel — researcher profile on SciRah

J. Striefler×7

Invite

J. Striefler — researcher profile on SciRah

Invite

H. Oettle — researcher profile on SciRah

Invite

F. Krenzien — researcher profile on SciRah

Invite

T. Malinka — researcher profile on SciRah

Invite

T. Auer — researcher profile on SciRah

Christopher C. M. Neumann×7

Invite

Christopher C. M. Neumann — researcher profile on SciRah

Invite

H. Riess — researcher profile on SciRah